Regeneron
Tarrytown, New York
Regeneron Pharmaceuticals is a biotechnology company known for its innovative therapies in ophthalmology, immunology, and oncology. Dupixent (dupilumab), co-developed with Sanofi, is one of the most prescribed biologics for atopic dermatitis, asthma, and other type 2 inflammatory conditions. Eylea (aflibercept) is a leading anti-VEGF therapy for retinal diseases.
Drugs
Hub Program — Regeneron Co-pay Card / MyWay Programs
- ✓Insurance verification and prior authorization support
- ✓Copay assistance — eligible patients may pay as little as $0
- ✓Patient assistance program for qualifying uninsured patients
- ✓Nurse support for self-injection training
- ✓Ongoing therapy support and refill coordination
Patient Assistance
Copay Assistance
Dupixent MyWay Copay Card can reduce copays to as little as $0 for eligible commercially insured patients. Eylea has separate copay assistance through retina specialist offices.
Patient Assistance Program (PAP)
Regeneron Patient Assistance Programs provide free medication to eligible uninsured patients.
Denied a Regeneron Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.